Unknown

Dataset Information

0

Adjuvant treatment with EGFR TKI in resected non-small cell lung cancer with EGFR mutation: all that glitters is not gold!

ABSTRACT:

SUBMITTER: Fiorelli A 

PROVIDER: S-EPMC7576010 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Adjuvant treatment with EGFR TKI in resected non-small cell lung cancer with EGFR mutation: all that glitters is not gold!

Fiorelli Alfonso A   Vitiello Fabiana F   Morgillo Floriana F   Di Crescenzo Rosa Maria RM   Bianco Andrea A   Santini Mario M   Di Domenico Marina M  

Annals of translational medicine 20200901 18

Similar Datasets

Unknown EGFR-TKI-based vs non-EGFR-TKI-based adjuvant therapy in resected non-small-cell lung cancer with EGFR mutations: a meta-analysis of randomized controlled trials.
| S-EPMC6188110 | biostudies-literature
Unknown Adjuvant TKI therapy in resected <i>EGFR</i>-mutant non-small-cell lung cancer-ready for prime time?
| S-EPMC7653106 | biostudies-literature
Unknown A meta-analysis of adjuvant EGFR-TKIs for patients with EGFR mutation of resected non-small cell lung cancer.
| S-EPMC9704950 | biostudies-literature
Unknown Evaluation of Cost-Effectiveness of Adjuvant Osimertinib in Patients with Resected EGFR Mutation-Positive Non-small Cell Lung Cancer.
| S-EPMC10169948 | biostudies-literature
Unknown Adjuvant EGFR TKI therapy for resectable non-small cell lung cancer: new era for personalized medicine.
| S-EPMC5906233 | biostudies-literature
Unknown EGFR TKI as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer.
| S-EPMC5650459 | biostudies-literature
Unknown The dawn of a new era, adjuvant EGFR inhibition in resected non-small cell lung cancer.
| S-EPMC8600554 | biostudies-literature
Unknown Specific TCR profiles predict clinical outcome of adjuvant EGFR-TKIs for resected EGFR-mutant non-small cell lung cancer.
| S-EPMC9990191 | biostudies-literature
Unknown Adjuvant EGFR-TKIs for Patients With Resected EGFR-Mutant Non-Small Cell Lung Cancer: A Meta-Analysis of 1,283 Patients.
| S-EPMC8071858 | biostudies-literature
Unknown Effectiveness comparison of third-generation EGFR-TKI as initial and sequential therapy in adjuvant treatment for EGFR mutation-sensitive stage IIIA non-small cell lung cancer after surgery.
| S-EPMC10618502 | biostudies-literature